Program Outcome Summary Grant #8458 (Draft)

Transcription

1 Promoting Resilience in Multiple Sclerosis Patients Program Outcome Summary Grant #8458 (Draft) Richard Lewis, PharmD, MBA Executive Director, ProCE, Inc. Office: (630) Prepared by: Valerie Smaga Office: (630) ProCE, Inc. is an independent continuing education provider that develops, delivers, and evaluates educational programs for healthcare professionals. This program is supported by an educational grant from TEVA Neuroscience.

2 CONTENTS Program Overview Learning Objectives Outcome Methodology Faculty Program Highlights Participants Program Evaluation Summary Achievement and Impact of Learning Objectives Impact of Program on Clinical Practice Change in Practice Behavior Effectiveness of Speaker and Overall Program Additional Participant Comments Suggestions for Future Programming Addendum A Outcome Levels Addendum B Sample Evaluation Form Page 2 of 11

3 PROGRAM OVERVIEW A continuing education program titled Promoting Resilience in Multiple Sclerosis Patients was presented at a live dinner symposium on June 22, 2011, in Cambridge, Mass. This CE activity focused on improving and maintaining resilience in MS patients. Optimal use of disease-modifying therapies, adherence to treatment, quality of life, and healthcare outcomes were discussed. In addition to evidence-based medicine, content was drawn from nursing, social work, and family intervention perspectives. Attendees gained a fresh outlook on improving quality of life for MS patients and their families, and learned the latest techniques to motivate patients and families and to make an observable difference. Nurses and physician assistants received 1.5 hours of continuing education credit for their participation in this educational activity. Accreditation for physician assistants was provided by the American Academy of Physician Assistants. Nursing credit was provided through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Learning Objectives At the conclusion of this program, participants should be able to: Outline the potential impact of treatment with disease-modifying drugs with regard to functional disability, quality of life, and health outcomes in patients with multiple sclerosis (MS) Explain the mechanisms by which early treatment of MS, in tandem with patient adherence with treatment, may slow the progression of disability Cite research-based patient factors that promote adherence to disease-modifying therapy in MS, as well as known obstacles to adherence Discuss methods for increasing the efficacy of MS patient care, including nursing modeling and role-modeling, collaborative therapy, the strengths-based approach, and solution-focused interventions Outcome Methodology Outcome levels are defined in this report according to the Expanded CME Framework described by Moore and colleagues. Please see Addendum A for a description of each outcome level. Faculty David Rintell, EdD Psychologist Partners Multiple Sclerosis Center Brigham and Women s Hospital Brookline, Massachusetts Lynn Stazzone, RN, MSN, ANP Partners Multiple Sclerosis Center Brigham and Women s Hospital Brookline, Massachusetts Program Highlights Data were obtained from evaluation forms submitted at the conclusion of the symposium. (See Addendum B for a sample evaluation form.) Approximately 87% of respondents indicated that they will apply the information provided to their practice (Outcome Level 4 Competence). Approximately 80% of respondents indicated that the learning objectives were achieved (Outcome Level 3A Learning: Declarative Knowledge). Attendees indicated a high level of satisfaction (94%) with the program design/content overall (Outcome Level 2 Satisfaction). Approximately 95% of respondents rated the faculty s teaching effectiveness (organization, delivery, and content) as very good to excellent (Outcome Level 2 Satisfaction). Page 3 of 11

4 Participants (Outcome Level 1 Participation) Target audience: Nurses, nurse practitioners, and physician assistants who manage patients with multiple sclerosis. Total attendees: 38 Physician Assistants 20% Other 3% Audience demographics: 23 Nurses 6 Physician Assistants 1 Other Nurses 77% PROGRAM EVALUATION SUMMARY Evaluation forms were distributed to attendees at the completion of each dinner symposium. Of the 38 attendees, 30 submitted evaluations. Achievement and Impact of Learning Objectives (Outcome Level 3A Learning: Declarative Knowledge) Key to summary below: 1=Strongly Disagree 2=Disagree 3=Neutral 4=Agree 5=Strongly Agree The learning objectives listed below were achieved: Outline the potential impact of treatment with disease-modifying drugs with regard to functional disability, quality of life, and health outcomes in patients with multiple sclerosis (MS) (n=27) Explain the mechanisms by which early treatment of MS, in tandem with patient adherence with treatment, may slow the progression of disability (n=27) Cite research-based patient factors that promote adherence to diseasemodifying therapy in MS, as well as known obstacles to adherence (n=27) Discuss methods for increasing the efficacy of MS patient care, including nursing modeling and role-modeling, collaborative therapy, the strengthsbased approach, and solution-focused interventions (n=28) Avg: 4.11 Min: 2 Avg: 4.11 Min: 2 Avg: 4.19 Min: 2 Avg: 4.46 Min: 1 Page 4 of 11

5 For each learning objective below, please check whether you will apply this information to your practice. (Outcome Level 4 Competence) Learning Objective Outline the potential impact of treatment with disease-modifying drugs with regard to functional disability, quality of life, and health outcomes in patients with multiple sclerosis (MS) (n=25) Explain the mechanisms by which early treatment of MS, in tandem with patient adherence with treatment, may slow the progression of disability (n=25) Cite research-based patient factors that promote adherence to disease-modifying therapy in MS, as well as known obstacles to adherence (n=25) Discuss methods for increasing the efficacy of MS patient care, including nursing modeling and role-modeling, collaborative therapy, the strengths-based approach, and solution-focused interventions (n=24) Number of Responses Yes No (Apply to (Not Apply Practice) to Practice) Impact of Program on Clinical Practice Please describe specifically what you learned today that you will apply to your practice. (Outcome Level 4 Competence) A number of these objectives can be developed to include geriatric patients Collaborative model - get everyone involved - use negative object and then convert into positive qualities Focus more on solutions - focused practice I love the approach to do small achievable goals - do one thing better Locate strengths and using strengths that patients exhibit in order to find a solution Looking to patients for inner strengths New understanding of what the medical illness means to the family Practical suggestions and tips Reinforcement of MS model and ROPES model - will apply to all patients in practice Resilience and how to work with clients Strategies that are concrete and effective The talk can be used with all kinds of chronic illness patients Think about various methods/models to interact and provide effective patient care Work as partners with patient and their family Page 5 of 11

6 Change in Practice Behavior I intend to make a change in my practice based on the information provided. (Outcome Level 4 Competence; n=28) Strongly Disagree Disagree Neutral Agree Strongly Agree 4% 0% 21% 50% 25% How do you plan to implement what you learned today in your practice? (Outcome Level 4 Competence) Able to use with any chronic illness As the talk happened, I thought of different patients of mine and will be able to try different strategies Can be used with many different patients and approaching different obstacles at work Inclusion of the family - knowing the background of what I am dealing with Placing more focus on strengths and acknowledging these with patients - continue to see patients as partners/collaborators in health care process Can use the principle discussed and can apply to all patients Focus on identifying patients strengths and use this in a collaborative process when providing patient care Stress patients strengths - stress the positive in patients life - shift focus - advocate resilience thoughts Target dialog with patient/family to empower them Focusing on finding my patients strengths instead of focusing on their weaknesses I can apply topics to dealing with difficult subjects with patients Unsure yet Utilize some of the models into my practice Will utilize strategies for strengthening resilience, which I learned today Page 6 of 11

7 What Barriers Do You Expect to Encounter? (Outcome Level 4 Competence) Clients who are unable to have the insight and ability to use the recommendation Denial, depression - negativism inactivity Disease progression, psychological and behavioral problems Experiences that are learned on behalf of the patient and me There's always adversity! To be seen Effectiveness of Speakers and Overall Program Effectiveness of Speakers and Overall Program (Outcome Level 2 Satisfaction) Key to summary below: 1=Poor 2=Fair 3=Good 4=Very Good 5=Excellent Teaching Effectiveness of Faculty Speakers Organization Delivery Content Audio-Visual Avg: 4.69 Avg: 4.69 Avg: 4.56 Avg: 4.67 Min: 3 Min: 3 Min: 3 Min: 3 Key to summary below: 1=Strongly Disagree 2=Disagree 3=Neutral 4=Agree 5=Strongly Agree The learning materials were appropriate and effective (Outcome Level 2 Satisfaction) The learning activities were appropriate and effective (Outcome Level 2 Satisfaction) The facility/location was conducive to learning (Outcome Level 2 Satisfaction) The program was fair balanced and lacked commercial bias (Outcome Level 2 Satisfaction) Avg: 4.52 Min: 1 Avg: 4.41 Min: 1 Avg: 4.69 Min: 1 Avg: 4.72 Min: 1 Page 7 of 11

8 Additional Participant Comments Excellent - both speakers are extremely articulate and geared to their target audience Focus on solutions - I like the way solutions are found - observe interaction and see the positive - setting achievable goals Good program Good speakers Great Great - one of the better ones that I've attended Great Job - I do not work with MS patients specifically, but I certainly work with patients who have chronic illnesses; sometimes disabling, who could benefit from resiliency theory/model and much of what was presented today Patient examples and comments about what works and what doesn't were useful Some of models are new The program was effective in making me think about how I approach patient care and can be applied to any difficult problem a patient may have The research was interesting but more updated theories on coping strategies (particularly related to current drug treatments) would have been beneficial Very interesting and well presented Very little regarding the treatment of MS - Enjoyed the speakers Well done Suggestions for future CE/CME programming: Cystitis or endocrine disorders Diabetes, CV disease Nutrition - food as 'drugs' PD Suggestions for programming on MS: Cognitive changes and how it relates in MS Effect on the family Essential tremors More discussion on drugs and prevention of complications New drugs New pharmacological approach to treat MS Skip the medical models and go right to the resilience model and expand Understanding MS meds Women's health issues How did you hear about this program? Mailed brochure 14 Colleague 7 8 Fax 1 Page 8 of 11

9 Addendum A Outcome Levels Moore DE Jr, Green JS, Gallis HA. Achieving desired results and improved outcomes: Integrating planning and assessment throughout learning activities. J Contin Educ Health Prof. 2009;29:1-15. Page 9 of 11

10 Addendum B Sample Evaluation Form Page 10 of 11

11 Page 11 of 11